These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11184821)

  • 1. Generic drug stocks: don't get hooked.
    McLean B
    Fortune; 2000 Oct; 142(10):250. PubMed ID: 11184821
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibiotics--an investment worth making?
    Christoffersen RE
    Nat Biotechnol; 2006 Dec; 24(12):1512-4. PubMed ID: 17160052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives. CMS and Wall Street report...
    Med Health; 2003 Jan; 57(4):7-8. PubMed ID: 12602066
    [No Abstract]   [Full Text] [Related]  

  • 4. Don't pay too much for generic fills. Pass-through pricing is a good way for a payer to realize the benefit of increased prescribing of generic drugs.
    Cahn LJ
    Manag Care; 2010 Nov; 19(11):21-7. PubMed ID: 21141372
    [No Abstract]   [Full Text] [Related]  

  • 5. Authorized generics.
    Glass G
    Nat Rev Drug Discov; 2005 Dec; 4(12):953-4. PubMed ID: 16370080
    [No Abstract]   [Full Text] [Related]  

  • 6. Rx for investors.
    Stires D
    Fortune; 2004 May; 149(9):158-60, 162, 164 passim. PubMed ID: 15124332
    [No Abstract]   [Full Text] [Related]  

  • 7. A generic problem.
    Hanauer SB
    Nat Clin Pract Gastroenterol Hepatol; 2006 Dec; 3(12):649. PubMed ID: 17130869
    [No Abstract]   [Full Text] [Related]  

  • 8. The new drug war.
    Sherrid P
    US News World Rep; 2002 Dec; 133(21):41. PubMed ID: 12503485
    [No Abstract]   [Full Text] [Related]  

  • 9. Handle with care.
    Macilwain C
    Nature; 2006 Apr; 440(7087):990-1. PubMed ID: 16625170
    [No Abstract]   [Full Text] [Related]  

  • 10. Lost sleep...
    Pontious JM
    J Okla State Med Assoc; 2002 Aug; 95(8):523. PubMed ID: 12185985
    [No Abstract]   [Full Text] [Related]  

  • 11. Correcting Hatch-Waxman.
    Fernandes M
    Health Aff (Millwood); 2008; 27(3):902-3; author reply 903. PubMed ID: 18475000
    [No Abstract]   [Full Text] [Related]  

  • 12. Why these biotechs are as hot as net stocks. Wall Street's betting big on a genetic technology that burned it badly before. Monoclonal antibodies still don't cure cancer--but this time they may actually pay off.
    McLean B
    Fortune; 2000 Jan; 141(1):132-4, 135. PubMed ID: 10788044
    [No Abstract]   [Full Text] [Related]  

  • 13. Congress works to permit 'biosimilar' drugs very soon.
    Carroll J
    Manag Care; 2009 Apr; 18(4):7-8. PubMed ID: 19472559
    [No Abstract]   [Full Text] [Related]  

  • 14. A few specialty drug prices fall--all generics.
    Manag Care; 2008 Dec; 17(12):46. PubMed ID: 19127766
    [No Abstract]   [Full Text] [Related]  

  • 15. Prozac. A bitter pill.
    McLean B
    Fortune; 2001 Aug; 144(3):118-22, 126, 130-2. PubMed ID: 11499050
    [No Abstract]   [Full Text] [Related]  

  • 16. Generic drugs: the stalling game.
    Consum Rep; 2001 Jul; 66(7):36-40. PubMed ID: 11725791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription drugs at bargain prices.
    Guglielmo WJ
    Newsweek; 2001 Apr; 137(17):62. PubMed ID: 11338630
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug costs threaten patent protection.
    Cimons M
    Nat Med; 2003 Jan; 9(1):9. PubMed ID: 12514706
    [No Abstract]   [Full Text] [Related]  

  • 19. RX for nosebleed prices.
    Greenwald J
    Time; 2001 May; 157(20):42-3. PubMed ID: 11383109
    [No Abstract]   [Full Text] [Related]  

  • 20. Inadequately met needs.
    Nat Biotechnol; 2011 May; 29(5):371. PubMed ID: 21552219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.